iHIVARNA Clinical Trial in HIV Infected Individuals

NCT02888756 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Interim analysis did not show sufficient immunogenicity of IMP compared to placebo

Conditions

HIV Infections

Interventions

BIOLOGICAL: iHIVARNA-01
BIOLOGICAL: TriMix
BIOLOGICAL: Placebo

Sponsor

Rob Gruters

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]